Not applicableNot Yet RecruitingNCT07777198What this trial is testingLiver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLDWho this might be right forMAFLD Beijing Friendship Hospital 2,303
Large-scale testing (Phase 3)Looking for participantsNCT07165028What this trial is testingA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Who this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease Eli Lilly and Company 4,500
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750What this trial is testingThe Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLDWho this might be right forT2DMMAFLD The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableLooking for participantsNCT07658755What this trial is testingAutomated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek ProgrammeWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLD+3 more Hospital General Universitario Gregorio Marañon 3,000
Not applicableLooking for participantsNCT07068191What this trial is testingGepaktiv vs UDCA and Ademetionine in MAFLD With HepatomegalyWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)HepatomegalyNonalcoholic Fatty Liver (NAFL)+5 more Phenomen Pharma 90
Testing effectiveness (Phase 2)Looking for participantsNCT05984745What this trial is testingEffect of CoQ10 on the Outcome of MAFLD PatientsWho this might be right forFatty LiverNAFLD Ain Shams University 60
Not applicableNot Yet RecruitingNCT07430501What this trial is testingUsing Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).Who this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableNot Yet RecruitingNCT07373769What this trial is testingUltrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver DiseaseWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver Disease University of British Columbia 145
Not applicableStudy completedNCT04551716What this trial is testingNoninvasive Assessment of Metabolic Associated Fatty Liver Disease (MAFLD) in Chinese PopulationWho this might be right forMetabolic-dysfunction-associated Fatty Liver Disease (MAFLD) Chinese PLA General Hospital 448
Not applicableNot Yet RecruitingNCT07085962What this trial is testingEfficacy and Safety of Calculus Bovis Sativus in Adults With MAFLDWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07637006What this trial is testingLinzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty LiverWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Hong Kong Baptist University 180
Not applicableNot Yet RecruitingNCT06795646What this trial is testingClinical Classification of MAFLD Based Liver BiopsyWho this might be right forMetabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH) Beijing Friendship Hospital 2,000
Not applicableNot Yet RecruitingNCT06749704What this trial is testingEffect of High Protein Diet on Hepatic Steatosis in Patients With MAFLDWho this might be right forMetabolic Dysfunction Associated Fatty Liver Disease Institute of Liver and Biliary Sciences, India 140
Large-scale testing (Phase 3)Active Not RecruitingNCT06884293What this trial is testingA Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）Who this might be right forOverweightMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Innovent Biologics (Suzhou) Co. Ltd. 479
Not applicableStudy completedNCT07539584What this trial is testingAdiponectin in Patients With Metabolic DisordersWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Type 2 Diabetes Mellitus (T2DM) Moscow Regional Research and Clinical Institute (MONIKI) 130
Not applicableNot Yet RecruitingNCT07177963What this trial is testingCPET-based HIIT for MAFLDWho this might be right forMetabolic Dysfunction-Associated Fatty Liver Disease Tang Yida 54
Not applicableLooking for participantsNCT05974904What this trial is testingAssociation of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional StudyWho this might be right forMetabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis Chongqing Medical University 7,000
Not applicableNot Yet RecruitingNCT06773221What this trial is testingThe Efficacy and Safety of Chiglitazar in Patients with MAFLD-related CirrhosisWho this might be right forMetabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis Beijing Friendship Hospital 195
Not applicableNot Yet RecruitingNCT07284004What this trial is testingFatty Liver in Long Standing CholecystectomyWho this might be right forMetabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Post-cholecystectomy Metabolic Changes -Hepatic Steatosis Yasmeen Ahmed Farrag Ahmed 100
Not applicableUnknownNCT06061640What this trial is testingThe Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning MethodsWho this might be right forMetabolic Dysfunction-associated Fatty Liver Disease The First Affiliated Hospital of Zhejiang Chinese Medical University 500